Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis

British Journal of Rheumatology

Volumn 36, Issue 2, 1997, Pages 251-254

  Font, C ^a,b   Cid, M C ^a   Coll Vinent, B ^a   Lopez Soto A ^a   Grau, J M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Amaurosis; Amaurosis fugax; Blindness; Corticosteroid therapy; Diplopia; Giant cell arteritis; Horton's disease; Vasculitis; Visual loss

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ARTICLE; BIOPSY; BLINDNESS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GIANT CELL ARTERITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; STEROID THERAPY; VISUAL IMPAIRMENT;

EID: 0030860702     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.251     Document Type: Article

References (14)

1. Goodman BW. Temporal arteritis. Am J Med 1979;67:839-52.
2. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell arteritis. Neurology 1988;38:352-9.
3. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100:550-5.
4. Liu GT, Glaser JS, Schatz NJ, Lawton-Smith J. Visual morbidity in giant cell arteritis. Ophthalmology 1994;101:1779-85.
5. Schneider HA, Weber AA, Ballen PH. The visual prognosis in temporal arteritis. Ann Ophthalmol 1978;62:591-4.
6. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 1979;24:111-7.
7. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. A 25-year epidemiological, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
8. Lipton RB, Solomon S, Wertenbaker C. Gradual loss and recovery of vision in temporal arteritis. Arch Intern Med 1985;145:2252-3.
9. Clearkin L, Caballero J. Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis. Am J Med 1992;92:703-4.
10. Model DG. Reversal of blindness in temporal arteritis with methylprednisolone. Lancet 1978;1:340.
11. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
12. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
13. Ayoub WT, Franklin CM, Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med 1985;79:309-15.
14. Hollenhorst RW, Brown JR, Wagener HP, Shick RM. Neurologic aspects of temporal arteritis. Neurology 1960;10:490-8.